Envair Electrodyne Limited (BOM:500246)
49.98
-1.02 (-2.00%)
At close: Oct 22, 2026
Envair Electrodyne Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
231.91M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | 3.97M | -5.75M | -59.14% |
| Mar 31, 2023 | 9.72M | -37.77M | -79.53% |
| Mar 31, 2022 | 47.49M | 39.58M | 500.46% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Taparia Tools | 10.64B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Medico Intercontinental | 838.36M |
| Takyon Networks | 710.53M |
| Olatech Solutions | 276.25M |
| ERP Soft Systems | 80.88M |
| Kamanwala Housing Construction | 78.21M |
| Laffans Petrochemicals | 57.46M |